Hargreaves Lansdown investors are buying Rolls-Royce shares and IAG. Here’s what I’d do

The IAG and Rolls-Royce share prices have staged a powerful rally since November. Roland asks if it’s too late to buy in to these reopening stocks.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Rolls-Royce Holdings (LSE: RR) shares were the most popular choice with investors on share trading platform Hargreaves Lansdown last week.

British Airways owner International Consolidated Airlines Group (LSE: IAG) wasn’t far behind, in second place by value.

Both companies are ‘reopening stocks’, which depend heavily on air travel getting back to normal over the next year. I’ve been wondering whether I should buy one of them for my portfolio, or whether it’s too late to get on board this trade.

What happens next?

The IAG and Roll-Royce share prices have both risen by more than 100% from the lows seen in early October. Vaccine news in November put a rocket under these stocks, as it did with many others.

Despite these gains, both Rolls-Royce and IAG are still trading at share prices 50% lower than in January 2020. At first glance, this might seem cheap. But I don’t think it is.

The reason for this is that both companies have taken on extra debt and issued large numbers of new shares over the last year. They’ve been focused on survival. But as a potential investor, I’m focused on dilution.

What this means is that from 2021 onwards, Rolls’ and IAG’s profits will be split among many more shares than in the past. This means that earnings per share will be much lower, even if profits return to pre-pandemic levels.

The extra debt these companies have taken on also worries me. Debt payments always come ahead of shareholder dividends. These payments will now be bigger than they were before the pandemic.

I think it could be a while before IAG and Rolls-Royce can start to pay attractive dividends again.

Rolls-Royce shares vs IAG: what I’d buy

The other concern I have as a potential buyer is whether these are really good businesses. Airlines have a long history of boom and bust. But before the pandemic, many investors — even Warren Buffett — were starting to think things might be different now.

It turns out they aren’t. Airlines still have high fixed costs that are difficult to manage when demand is disrupted. And they still face very tough competition from multiple rivals.

Mr Buffett ditched his airline stocks early last year when the likely impact of the pandemic became clear.

In my view, Rolls-Royce is a better business than IAG. This is because Rolls-Royce offers essential products with few competitors and a large base of existing customers. These customers are tied into Rolls on long-term maintenance contracts. When flying restarts, airlines will have to start spending money with Rolls-Royce again.

To sum up, I don’t think Rolls-Royce shares or IAG shares look particularly cheap today. But if I did invest, I’d certainly choose Rolls. I think the engine maker is much more likely to deliver attractive long-term returns for shareholders.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Hargreaves Lansdown. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »